Evaluation of Initial and Steady-State Gatifloxacin Pharmacokinetics and Dose in Pulmonary Tuberculosis Patients by Using Monte Carlo Simulations

A 4-month regimen of gatifloxacin with rifampin, isoniazid, and pyrazinamide is being evaluated for the treatment of tuberculosis in a phase 3 randomized controlled trial (OFLOTUB). A prior single-dose study found that gatifloxacin exposure increased by 14% in the combination. The aims of the study...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Smythe, Wynand, Merle, Corinne S., Rustomjee, Roxana, Gninafon, Martin, Lo, Mame Bocar, Bah-Sow, Oumou, Olliaro, Piero L., Lienhardt, Christian, Horton, John, Smith, Peter, McIlleron, Helen, Simonsson, Ulrika S. H.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2013
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754315/
https://ncbi.nlm.nih.gov/pubmed/23774436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00479-13
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items